Recent years have witnessed groundbreaking progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://deaconkdrn805654.blog5.net/87695086/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements